ヘルスケア分析/医療分析の世界市場予測(~2022年)

◆英語タイトル:Healthcare Analytics/Medical Analytics Market by Type (predictive, prescriptive) Application (Clinical, RCM, Claim, Fraud, Waste, Supply Chain, PHM) Component (Service, Software) Delivery (On demand, Cloud) End User (Payer, Hospital, ACO) - Global Forecast to 2022
◆発行会社/調査会社:MarketsandMarkets
◆商品コード:HIT-2180
◆発行日:2017年11月22日
◆調査対象地域:グローバル
◆産業分野:IT
◆ページ数:364
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の市場調査資料のご購入、委託調査サービスに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[ヘルスケア分析/医療分析の世界市場予測(~2022年)]についてメールでお問い合わせはこちら
MarketsandMarketsが発行した当調査レポートでは、ヘルスケア分析/医療分析の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、アプリケーション別分析、構成要素別分析、需要先別分析、ヘルスケア分析/医療分析の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
*** レポート概要(サマリー)***

“Global healthcare analytics market projected to grow at a CAGR of 27.3%”The healthcare analytics market is expected to reach USD 29.84 billion by 2022 from USD 8.92 billion in 2017, at a CAGR of 27.3%. Increasing government initiatives to increase EHR adoption, growing pressure to curb healthcare costs, availability of big data in healthcare, increasing venture capital investments, rising focus on improving patient outcomes, and technological advancements are driving the growth of the healthcare analytics market. On the other hand, factors like the lack of skilled analysts (that limits the use of healthcare solutions), the high cost of these solutions, and operational gaps between payers and providers, are expected to limit the growth of this market to a certain extent.

“The prescriptive analytics segment is expected to grow at the highest CAGR during the forecast period”
By type, the healthcare analytics market is segmented into descriptive, predictive, and prescriptive analytics. The prescriptive analytics segment is expected grow at a highest CAGR during the forecast period. The high growth of this segment is attributed to the ability of prescriptive analytics to ensure the synergistic integration of predictions and prescriptions.

“Financial analytics are expected to hold the largest share of the market in 2017”
Based on application, the healthcare analytics market is segmented into clinical analytics, financial analytics, operational and administrative analytics, and population health analytics. Financial analytics market is segmented into revenue cycle management; claims processing; payment integrity and fraud, waste, & abuse (FWA); and risk adjustment and risk assessment. Due to the rising focus of payers on the early detection of fraud and reducing preventable costs, the market for fraud analytics is expected to register a significant growth during the forecast period, therefore driving the market for financial analytics.
“The services segment is expected to dominate the market during the forecast period”
Based on the component, the healthcare analytics market is segmented into services, software, and hardware. The services segment accounted for the largest share of the healthcare analytics market in 2016. With the increasing need for business analytics services and the introduction of technologically advanced healthcare analytics software, which requires extensive training to use as well as regular upgrades, the services segment is expected to grow at the highest CAGR during the forecast period.
“North America to witness high growth during the forecast period”
In 2017, North America is expected to account for the largest share of the market followed by Europe. This regional segment is expected to register the highest CAGR during the forecast period. Factors such as growing federal healthcare mandates to curb rising healthcare costs and provide quality care; increasing regulatory requirements; growing EHR adoption; and rising government initiatives focusing on personalized medicine, population health management, and value-based reimbursements are expected to drive market growth in North America.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 33%; Tier 2 – 45%; Tier 3 – 22%.
• By Designation (Supply Side): C-level- 22%; D-level- 28%; others- 50%.
• By Designation (Demand Side): Hospital IT Manager- 21%, Insurance Companies- 35%, Others:- 44%
• By Region: North America-62%; Europe-13%; Asia-21%; RoW-4%.

List of companies profiled in the report
• Allscripts (US),
• Cerner (US)
• Health Catalyst (US)
• IBM (US)
• Inovalon (US)
• McKesson (US)
• MedeAnalytics (US)
• Optum (US)
• Oracle (US)
• SAS (US)
• Wipro (India)
• Verscend (US)
• CitusTech (US)
• VitreosHealth (US)
• SCIO Health (US)

Research Coverage:
The report provides an overview of the healthcare analytics market. It aims at estimating the market size and future growth potential of this market across different segments such as type, application, component, delivery model, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall healthcare analytics market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

*** レポート目次(コンテンツ)***

TABLE OF CONTENTS

1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 MARKET SCOPE 27
1.3.1 MARKETS COVERED 27
1.3.2 GEOGRAPHIC SCOPE 28
1.3.3 YEARS CONSIDERED FOR THE STUDY 28
1.4 CURRENCY 28
1.5 LIMITATIONS 29
1.6 STAKEHOLDERS 29
2 RESEARCH METHODOLOGY 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Secondary sources 31
2.1.2 PRIMARY DATA 32
2.1.2.1 Primary sources 32
2.1.2.2 Breakdown of primary interviews: by company type, designation, and Region 33
2.1.2.3 Key industry insights 33
2.2 MARKET SIZE ESTIMATION 34
2.2.1 BOTTOM-UP APPROACH 34
2.2.2 TOP-DOWN APPROACH 35
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 36
2.4 ASSUMPTIONS FOR THE STUDY 37
3 EXECUTIVE SUMMARY 38
4 PREMIUM INSIGHTS 44
4.1 HEALTHCARE ANALYTICS: MARKET OVERVIEW 44
4.2 HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL 45
4.3 HEALTHCARE ANALYTICS MARKET, BY TYPE 45
4.4 ASIA HEALTHCARE ANALYTICS MARKET, BY APPLICATION 46
4.5 HEALTHCARE ANALYTICS MARKET, BY COMPONENT 47
4.6 HEALTHCARE ANALYTICS MARKET, BY END USER 47
4.7 GEOGRAPHIC SNAPSHOT OF THE HEALTHCARE ANALYTICS MARKET 48

5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
5.2.1 DRIVERS 50
5.2.1.1 Implementation of government initiatives to increase EHR adoption 50
5.2.1.2 Growing venture capital investments 51
5.2.1.3 Growing pressure to curb healthcare spending and improve patient outcomes 52
5.2.1.4 Big data in healthcare 54
5.2.1.5 Launch of new/upgraded healthcare analytics solutions and services 54
5.2.2 RESTRAINTS 55
5.2.2.1 Dearth of skilled personnel 55
5.2.2.2 High cost of analytics solutions 55
5.2.3 OPPORTUNITIES 55
5.2.3.1 Increasing focus on value-based medicine 55
5.2.3.2 Use of analytics in precision and personalized medicine 56
5.2.3.3 Cloud-based analytics 57
5.2.3.4 Increasing number of patient registries 57
5.2.3.5 Emergence of social media and its impact on the healthcare industry 58
5.2.4 CHALLENGES 58
5.2.4.1 Patient data confidentiality 58
5.2.4.2 Concerns regarding inaccurate and inconsistent data 58
5.2.4.3 Reluctance to adopt healthcare analytics in emerging countries 59
5.2.4.4 Data integration 59
5.2.4.5 Operational gaps between payers and providers 59
6 HEALTHCARE ANALYTICS MARKET, BY TYPE 60
6.1 INTRODUCTION 61
6.2 DESCRIPTIVE ANALYTICS 62
6.3 PREDICTIVE ANALYTICS 65
6.4 PRESCRIPTIVE ANALYTICS 69
7 HEALTHCARE ANALYTICS MARKET, BY COMPONENT 73
7.1 INTRODUCTION 74
7.2 SERVICES 75
7.2.1 SUPPORT SERVICES 78
7.2.2 BUSINESS ANALYTICS SERVICES 81
7.3 SOFTWARE 83
7.4 HARDWARE 86

8 HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL 89
8.1 INTRODUCTION 90
8.2 ON-PREMISE HEALTHCARE ANALYTICS 91
8.3 ON-DEMAND HEALTHCARE ANALYTICS 94
9 HEALTHCARE ANALYTICS MARKET, BY APPLICATION 98
9.1 INTRODUCTION 99
9.2 FINANCIAL ANALYTICS 100
9.2.1 CLAIMS PROCESSING 104
9.2.2 REVENUE CYCLE MANAGEMENT (RCM) 107
9.2.3 PAYMENT INTEGRITY AND FRAUD, WASTE, AND ABUSE (FWA) 110
9.2.4 RISK ADJUSTMENT AND RISK ASSESSMENT 113
9.3 CLINICAL ANALYTICS 116
9.3.1 QUALITY IMPROVEMENT AND CLINICAL BENCHMARKING 121
9.3.2 CLINICAL DECISION SUPPORT 124
9.3.3 REGULATORY REPORTING AND COMPLIANCE 127
9.3.4 COMPARATIVE ANALYTICS/ EFFECTIVENESS 129
9.3.5 PRECISION HEALTH 132
9.4 OPERATIONAL AND ADMINISTRATIVE ANALYTICS 135
9.4.1 SUPPLY CHAIN ANALYTICS 139
9.4.2 WORKFORCE ANALYTICS 142
9.4.3 STRATEGIC ANALYTICS 145
9.5 POPULATION HEALTH ANALYTICS 147
9.5.1 APPLICATIONS OF POPULATION HEALTH ANALYTICS 150
9.5.1.1 Population risk management 150
9.5.1.2 Population care management 150
9.5.1.3 Patient engagement 150
9.5.1.4 Clinical outcome management 151
9.5.1.5 Activity-based costing 151
9.5.2 MARKET DRIVERS FOR POPULATION HEALTH ANALYTICS 151
9.5.2.1 Rising number of accountable care organizations 151
9.5.2.2 Increasing costs of chronic disease treatment 151
9.5.2.3 Initiatives for population health management 152
9.5.3 MARKET RESTRAINTS FOR POPULATION HEALTH ANALYTICS 152
9.5.3.1 Lack of data management capabilities and skilled analysts 152

10 HEALTHCARE ANALYTICS MARKET, BY END USER 153
10.1 INTRODUCTION 154
10.2 PAYERS 155
10.2.1 PRIVATE INSURANCE COMPANIES 159
10.2.2 GOVERNMENT AGENCIES 161
10.2.3 EMPLOYERS AND PRIVATE EXCHANGES 164
10.3 PROVIDERS 166
10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS 170
10.3.2 POST-ACUTE CARE ORGANIZATIONS 173
10.3.3 AMBULATORY SETTINGS 176
10.4 ACOS, HIES, MCOS, AND TPAS 179
11 HEALTHCARE ANALYTICS MARKET, BY REGION 183
11.1 INTRODUCTION 184
11.2 NORTH AMERICA 184
11.2.1 US 192
11.2.2 CANADA 198
11.3 EUROPE 205
11.3.1 GERMANY 213
11.3.2 UK 219
11.3.3 FRANCE 225
11.3.4 REST OF EUROPE 231
11.4 ASIA 237
11.4.1 JAPAN 245
11.4.2 CHINA 251
11.4.3 INDIA 257
11.4.4 REST OF ASIA 263
11.5 PACIFIC COUNTRIES 269
11.6 LATIN AMERICA 275
11.7 MIDDLE EAST AND AFRICA 281
12 COMPETITIVE LANDSCAPE 288
12.1 OVERVIEW 288
12.2 MARKET RANK ANALYSIS 290
12.3 COMPETITIVE SCENARIO 292
12.3.1 PARTNERSHIPS, AGREEMENTS, COLLABORATIONS, AND ALLIANCES 292
12.3.2 PRODUCT AND SERVICE LAUNCHES, PRODUCT UPGRADES, AND PRODUCT ENHANCEMENTS 293
12.3.3 ACQUISITIONS 294
12.3.4 EXPANSIONS 295

13 COMPANY PROFILES 296
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
13.1 ALLSCRIPTS HEALTHCARE SOLUTIONS 296
13.2 CERNER 302
13.3 HEALTH CATALYST 306
13.4 IBM 311
13.5 INOVALON 316
13.6 MCKESSON 319
13.7 MEDEANALYTICS 323
13.8 OPTUM 326
13.9 ORACLE 331
13.10 SAS INSTITUTE 335
13.11 SCIO HEALTH ANALYTICS 339
13.12 VERSCEND TECHNOLOGIES 342
13.13 CITIUSTECH 344
13.14 WIPRO 347
13.15 VITREOSHEALTH 350
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.
14 APPENDIX 352
14.1 INSIGHTS FROM INDUSTRY EXPERTS 352
14.2 DISCUSSION GUIDE 353
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 357
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 359
14.5 AVAILABLE CUSTOMIZATIONS 360
14.6 RELATED REPORTS 361
14.7 AUTHOR DETAILS 362



LIST OF FIGURES

FIGURE 1 MARKET SEGMENTATION 27
FIGURE 2 RESEARCH DESIGN 30
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 34
FIGURE 4 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 35
FIGURE 5 DATA TRIANGULATION 36
FIGURE 6 DESCRIPTIVE ANALYTICS SEGMENT TO DOMINATE THE HEALTHCARE ANALYTICS MARKET, BY TYPE, DURING THE FORECAST PERIOD 38
FIGURE 7 CLINICAL ANALYTICS SEGMENT TO GROW AT THE HIGHEST RATE (2017–2022) 39
FIGURE 8 SERVICES MARKET TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES 40
FIGURE 9 ON-DEMAND DELIVERY MODEL TO GROW AT THE HIGHEST RATE 41
FIGURE 10 HEALTHCARE PROVIDERS SEGMENT TO REGISTER THE HIGHEST CAGR IN THE END-USER MARKET 42
FIGURE 11 NORTH AMERICA TO HOLD THE LARGEST SHARE OF THE GLOBAL MARKET DURING 2017 TO 2022 43
FIGURE 12 INCREASING GOVERNMENT INITIATIVES AND GROWING PRESSURE TO CURB HEALTHCARE COSTS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 44
FIGURE 13 ON-DEMAND HEALTHCARE ANALYTICS TO OFFER HIGH GROWTH OPPORTUNITIES 45
FIGURE 14 DESCRIPTIVE ANALYTICS DOMINATES THE GLOBAL HEALTHCARE ANALYTICS MARKET 45
FIGURE 15 FINANCIAL ANALYTICS TO HOLD THE LARGEST SHARE OF THE ASIAN HEALTHCARE ANALYTICS MARKET IN 2017 46
FIGURE 16 SERVICES SEGMENT TO GROW AT THE HIGHEST CAGR 47
FIGURE 17 PROVIDERS SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 47
FIGURE 18 US TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 48
FIGURE 19 HEALTHCARE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
FIGURE 20 EHR ADOPTION RATE AMONG HEALTHCARE PROVIDERS IN THE US (2014–2016) 50
FIGURE 21 HEALTHCARE SPENDING AS A PERCENTAGE OF GDP, BY COUNTRY, 2015 53
FIGURE 22 PRESCRIPTIVE ANALYTICS MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 61
FIGURE 23 NORTH AMERICA DOMINATES THE GLOBAL DESCRIPTIVE ANALYTICS MARKET (2017–2022) 62
FIGURE 24 ANALYTICS SERVICES SEGMENT TO DOMINATE THE HEALTHCARE ANALYTICS MARKET IN 2017 74
FIGURE 25 ON-DEMAND HEALTHCARE ANALYTICS TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD (2017–2022) 90
FIGURE 26 NORTH AMERICA TO DOMINATE THE ON-PREMISE HEALTHCARE ANALYTICS MARKET DURING THE FORECAST PERIOD 92
FIGURE 27 CLINICAL ANALYTICS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 99
FIGURE 28 PAYMENT INTEGRITY AND FRAUD ANALYTICS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 101
FIGURE 29 QUALITY IMPROVEMENT AND CLINICAL BENCHMARKING SEGMENT TO DOMINATE THE CLINICAL ANALYTICS MARKET 118
FIGURE 30 SUPPLY CHAIN ANALYTICS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 136
FIGURE 31 PAYERS TO DOMINATE THE HEALTHCARE ANALYTICS MARKET DURING THE FORECAST PERIOD 154
FIGURE 32 PRIVATE INSURANCE COMPANIES TO DOMINATE THE PAYERS MARKET DURING THE FORECAST PERIOD 156
FIGURE 33 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD 167
FIGURE 34 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SNAPSHOT 185
FIGURE 35 EUROPE: HEALTHCARE ANALYTICS MARKET SNAPSHOT 206
FIGURE 36 ASIA: HEALTHCARE ANALYTICS MARKET SNAPSHOT 238
FIGURE 37 KEY PLAYERS ADOPTED INORGANIC GROWTH STRATEGIES BETWEEN
2014 AND 2017 289
FIGURE 38 MARKET EVOLUTION FRAMEWORK - PARTNERSHIPS, AGREEMENTS, COLLABORATIONS, AND ALLIANCES FUELLED MARKET GROWTH 290
FIGURE 39 ALLSCRIPTS: COMPANY SNAPSHOT 296
FIGURE 40 CERNER: COMPANY SNAPSHOT 302
FIGURE 41 IBM: COMPANY SNAPSHOT 311
FIGURE 42 INOVALON: COMPANY SNAPSHOT 316
FIGURE 43 MCKESSON: COMPANY SNAPSHOT 319
FIGURE 44 UNITEDHEALTH GROUP: COMPANY SNAPSHOT 326
FIGURE 45 ORACLE: COMPANY SNAPSHOT 331
FIGURE 46 SAS INSTITUTE: COMPANY SNAPSHOT 335
FIGURE 47 WIPRO: COMPANY SNAPSHOT 347


*** レポートのキーワード ***

ヘルスケア分析、医療分析

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(HIT-2180 )"ヘルスケア分析/医療分析の世界市場予測(~2022年)" (英文:Healthcare Analytics/Medical Analytics Market by Type (predictive, prescriptive) Application (Clinical, RCM, Claim, Fraud, Waste, Supply Chain, PHM) Component (Service, Software) Delivery (On demand, Cloud) End User (Payer, Hospital, ACO) - Global Forecast to 2022)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。